Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

7.7%

1 terminated/withdrawn out of 13 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

69%

9 trials in Phase 3/4

Results Transparency

100%

12 of 12 completed trials have results

Key Signals

12 with results

Enrollment Performance

Analytics

Phase 3

5(38.5%)

Phase 4

4(30.8%)

Phase 2

3(23.1%)

Phase 1

1(7.7%)

13Total

Phase 3(5)

Phase 4(4)

Phase 2(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials

NCT01252810Phase 2Completed

Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure

Role: collaborator

NCT01028053Phase 3Completed

Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease

Role: collaborator

NCT00908310Phase 4Completed

Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)

Role: collaborator

NCT01475097Phase 4Completed

Comparing Patient Comfort and Safety Between Iodixanol and Iopamidol in Patients Undergoing Peripheral Arteriography

Role: collaborator

NCT00918281Phase 2Completed

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

Role: collaborator

NCT01376089Phase 4Completed

Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis

Role: collaborator

NCT01092546Phase 3Terminated

Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Role: collaborator

NCT01165554Phase 3Completed

Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels

Role: collaborator

NCT01265394Phase 3Completed

Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects

Role: collaborator

NCT00382967Phase 4Completed

A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms

Role: collaborator

NCT01053312Phase 3Completed

PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Role: collaborator

NCT01004770Phase 1Completed

Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)

Role: collaborator

NCT00785759Phase 2Completed

Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers

Role: collaborator

All 13 trials loaded